Organoids: A Platform Ready for Glioblastoma Precision Medicine?
Trends Cancer
; 6(4): 265-267, 2020 04.
Article
em En
| MEDLINE
| ID: mdl-32209439
ABSTRACT
Patient-derived organoids can recapitulate parental tumor heterogeneity. In a recent study in Cell, Jacob et al. cultivated glioblastoma organoids (GBOs) to mimic tumor heterogeneity and chimeric antigen receptor (CAR)-T cell immunotherapy, applied it for xenograft establishment and drug testing, and generated a biobank for the timely start of post-operation therapy.
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
/
Tipos_de_cancer
/
Outros_tipos
Base de dados:
MEDLINE
Assunto principal:
Glioblastoma
/
Receptores de Antígenos Quiméricos
Limite:
Humans
Idioma:
En
Revista:
Trends Cancer
Ano de publicação:
2020
Tipo de documento:
Article